Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2020 Nov 27;161(3):760–771.e2. doi: 10.1016/j.jtcvs.2020.10.148

FIGURE 5.

FIGURE 5.

In a cohort of 164 patients from 5 North American cancer centers spanning from 1986 to 2019. Resected limited-stage small cell cancer patients receive overall survival benefit from adjuvant chemotherapy. The benefit of postoperative radiation therapy (PORT) and prophylactic cranial irradiation (PCI) should be individualized.